Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients

NACompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

March 1, 2012

Primary Completion Date

June 1, 2012

Study Completion Date

March 1, 2013

Conditions
Lupus NephritisLupus Erythematosus, Systemic
Interventions
OTHER

Experimental - Test Results and Education

"First, these providers will receive educational materials (e.g. a slide deck, mock test result and one-page fact sheet) meant to mimic what physicians will receive in the real-world market as they learn about the DxTerity test.~Second, within each of their second-round cases, intervention-arm physicians only will receive simulated test results from the DxTerity test at the clinically-appropriate point in each case."

Trial Locations (1)

94133

QURE Healthcare, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DxTerity Diagnostics

INDUSTRY

lead

Qure Healthcare, LLC

INDUSTRY

NCT04266860 - Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients | Biotech Hunter | Biotech Hunter